Tang Capital Management
Tang Capital Management reported 44 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AUPH (9.8%), CORT (8.0%) and KNSA (7.8%). Compared with Q2 2026, the fund opened new positions in ARDX, VERA and LEGN, added to TARS, LKFT and CELC, trimmed SPY and sold out of CAPR and WVE.
Latest filing: what Tang Capital Management did in Q3 2026
vs Q2 2026
SPY−$21.4M−23%
Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() AUPH Aurinia Pharmaceuticals Inc | $211M | 9.8% | 13M | No change | 8 of 8 | |
| 2 | ![]() CORT Corcept Therapeutics Inc | $173M | 8.0% | 1.5M | No change | 4 of 8 | |
| 3 | ![]() KNSA Kiniksa Pharmaceuticals Intl | $169M | 7.8% | 2.3M | No change | 8 of 8 | |
| 4 | ![]() SYRE Spyre Therapeutics Inc | $168M | 7.8% | 1.9M | No change | 7 of 8 | |
| 5 | ![]() TARS Tarsus Pharmaceuticals Inc | $151M | 7.0% | 1.9M | +349K (+22%) | 8 of 8 | |
| 6 | ![]() LKFT Galapagos NV | $118M | 5.5% | 4M | +200K (+5%) | 8 of 8 | |
| 7 | ![]() CELC Celcuity Inc | $116M | 5.4% | 1.5M | +150K (+11%) | 5 of 8 | |
| 8 | ![]() MIRM Mirum Pharmaceuticals Inc | $106M | 4.9% | 1.2M | No change | 8 of 8 | |
| 9 | ![]() PTCT Ptc Therapeutics Inc | $97.2M | 4.5% | 1.5M | No change | 8 of 8 | |
| 10 | ![]() IMCR Immunocore Hldgs PLC | $87.4M | 4.0% | 2.9M | +235K (+9%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() CAPR Capricor Therapeutics Inc | $98.7M | 4.1M |
![]() WVE Wave Life Sciences Ltd | $3.5M | 600K |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Tang Capital Management 13F FAQ
What does Tang Capital Management own?
Tang Capital Management reported 44 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AUPH (9.8%), CORT (8.0%) and KNSA (7.8%). The table above lists every position in the filing (the top 10 without an account).
What did Tang Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 6 new positions, 12 added to, 1 trimmed and 2 sold out. New positions include ARDX, VERA and LEGN. It sold all of CAPR and WVE.
When will Tang Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Tang Capital Management's portfolio worth?
The Q3 2026 filing reports $2.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.

















